首页 | 本学科首页   官方微博 | 高级检索  
检索        

雷奈酸锶通过TGF-β1/Smad通路促进骨髓间充质干细胞向成骨细胞分化
引用本文:黄晓丹,吕辉珍,靳思思,郭润民,吴文.雷奈酸锶通过TGF-β1/Smad通路促进骨髓间充质干细胞向成骨细胞分化[J].中国病理生理杂志,2013,29(2):302-307.
作者姓名:黄晓丹  吕辉珍  靳思思  郭润民  吴文
作者单位:1南方医科大学,广东 广州 510515;2广东省医学科学院,广东省人民医院东病区内分泌科,广东 广州 510080; 3中山大学医学院生理学教研室,广东 广州 510080
基金项目:广东省自然科学基金资助项目(No.S2012010009403);广东省科技计划项目(No.2011B031800002);广州市科技计划项目(No.2012J4300082)
摘    要: 摘 要] 目的:研究转化生长因子β1(TGF-β1)/Smad通路在雷奈酸锶(strontium ranelate,Sr)促进大鼠骨髓间充质干细胞(BMSCs)向成骨细胞分化中的作用。方法: 在大鼠BMSCs向成骨细胞的诱导分化过程中,用Sr处理细胞,用Western blotting法检测磷酸化Smad2(phosphorylated Smad2,p-Smad2)和Runx2的表达。用TGF-β1特异性阻断剂SB431542或Smad2小干扰RNA(Smad2-siRNA)预处理BMSCs后加入Sr,再观察p-Smad2和Runx2表达的改变。应用试剂盒检测碱性磷酸酶(alkaline phosphatase,ALP)活性及钙结节水平。结果: 在大鼠BMSCs向成骨细胞的诱导分化过程中,Sr可增加p-Smad2和Runx2的表达,Sr 浓度为1 mmol/L、作用1 h时,p-Smad2表达最多;Sr 浓度为1 mmol/L、作用5 d时,Runx2表达最多;用SB431542或Smad2-siRNA预处理BMSCs后再加入Sr,不仅可以抑制p-Smad2和Runx2的表达,且ALP活性与钙结节数量也受到明显的抑制。结论: Sr可通过TGF-β1/Smad通路促进大鼠BMSCs向成骨细胞分化。

关 键 词:[关键词]  雷奈酸锶  骨髓间充质干细胞  转化生长因子β  Smad2蛋白  Runx2蛋白  
收稿时间:2012-11-28

Strontium ranelate promotes osteogenic differentiation of rat bone mesenchymal stem cells through TGF-β1/Smad signaling pathway
HUANG Xiao-dan,Lü Hui-zhen,JIN Si-si,GUO Run-min,WU Wen.Strontium ranelate promotes osteogenic differentiation of rat bone mesenchymal stem cells through TGF-β1/Smad signaling pathway[J].Chinese Journal of Pathophysiology,2013,29(2):302-307.
Authors:HUANG Xiao-dan  Lü Hui-zhen  JIN Si-si  GUO Run-min  WU Wen
Institution:1Southern Medical University, Guangzhou 510515, China; 2Guangdong Academy of Medical Sciences, Department of Endocrinology, East Ward, Guangdong General Hospital, Guangzhou 510080, China; 3Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Abstract:ABSTRACT] AIM: To study the roles of transforming growth factor β1 (TGF-β1)/Smad signaling pathway in strontium ranelate (Sr)-induced osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs). METHODS: In the process of osteogenic differentiation of rat BMSCs, the expression of phosphorylated Smad2 (p-Smad2) and Runx2 was detected by Western blotting after the cells were treated with Sr. BMSCs were pretreated with SB431542, a selective inhibitor of TGF-β1, or Smad2 small interfering RNA (Smad2-siRNA), followed by Sr treatment, and then the expression of p-Smad2 and Runx2 was observed. At the same time, the activity of alkaline phosphatase (ALP) and the level of calcium nodules were detected to determine the osteogenic differentiation of BMSCs. RESULTS: The expression levels of p-Smad2 and Runx2 were enhanced under the action of Sr in the process of osteogenic differentiation of rat BMSCs. The expression of p-Smad2 reached to maximum when BMSCs were treated with Sr at concentration of 1 mmol/L for 1 h. The expression of Runx2 reached to maximum when BMSCs were treated with Sr at concentration of 1 mmol/L for 5 d. The pretreatment with SB431542 or Smad2-siRNA inhibited not only the expression of p-Smad2 and Runx2, but also the activity of ALP and the level of calcium nodules. CONCLUSION: Sr promotes the osteogenic differentiation of rat BMSCs through the TGF-β1/Smad signaling pathway.
Keywords:[KEY WORDS] Strontium ranelate  Bone marrow mesenchymal stem cells  Transforming growth factor beta  Smad2 protein  Runx2 protein
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号